Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
CTI BioPharma
CTI BioPharma
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Rutgers, The State University of New Jersey
University of California, San Francisco